Jie-Yu Pill, A Proprietary Herbal Medicine, Ameliorates Mood Disorder-Like Behavior and Cognitive Impairment in Estrogen-Deprived Mice Exposed to Chronic Unpredictable Mild Stress: Implication for a Potential Therapy of Menopause Syndrome

Xi-Dan Zhou,Xin-Jing Yang,Yu Zheng,Zong-Shi Qin,Wei Sha,Gang Chen,Zhang-Jin Zhang
DOI: https://doi.org/10.3389/fpsyt.2020.579995
IF: 4.7
2020-10-29
Frontiers in Psychiatry
Abstract:Jie-Yu Pill (JYP) is a proprietary herbal medicine initially developed to treat menstrual mood disorders. This study sought to determine whether JYP could alleviate menopausal psychiatric symptoms in ovariectomized (OVX) mice, an animal model of estrogen deprivation, exposed to chronic unpredictable mild stress (CUMS) and the underlying mechanisms in comparison with estrogen therapy. The OVX+CUMS mice were treated with 0.3 mg/kg estradiol (E<sub>2</sub>), 2.5 g/kg or 5 g/kg JYP for 36 days, and tested in multiple behavioral paradigms. Serum, uterus, and brain tissues were collected for the measurement of hypothalamus-pituitary-ovarian axis (HPO) and hypothalamus-pituitary-adrenal (HPA) axis hormones, γ-aminobutyric acid (GABA), glutamate, neurotrophins, and estrogen receptors. JYP and E<sub>2</sub> had comparable efficacy in reducing anxiety- and depression-like behavior and cognitive impairment of the OVX+CUMS mice. E<sub>2</sub> strikingly increased ratio of uterus to body weight of the OVX+CUMS mice, but JYP did not. Both agents suppressed HPO-axis upstream hormones, inhibited HPA-axis hyperactivity by reinstating hypothalamic GABA, restored hippocampal and prefrontal glutamate contents and its receptor expression in the OVX+CUMS mice. While JYP and E<sub>2</sub> protected against decreases in hippocampal and prefrontal neurotrophins and estrogen receptors of the OVX+CUMS mice, unlike E<sub>2</sub>, JYP had no significant effects on these biomarkers in the uterus. These results suggest that JYP has comparable efficacy in ameliorating mood disorder-like behavior and cognitive impairment induced by a combination of estrogen deprivation and chronic stress in association with certain differential uterus-brain mechanisms compared to estrogen therapy. JYP may be a potential therapy for menopause-associated psychiatric disorders.
psychiatry
What problem does this paper attempt to address?
This paper aims to explore whether Jie - Yu Pill (JYP) can relieve mood - disorder - like behaviors and cognitive dysfunctions in mice induced by the combined effects of estrogen deprivation and chronic unpredictable mild stress (CUMS). Specifically, the researchers used ovariectomized (OVX) mice as an animal model of estrogen deprivation and combined it with CUMS treatment to simulate the common psychological symptoms in menopausal syndrome. By comparing with estrogen treatment, the effects of Jie - Yu Pill in improving these symptoms and its potential mechanisms were studied. The main objectives of the study were: 1. **To evaluate the effects of Jie - Yu Pill on mood - disorder - like behaviors and cognitive dysfunctions in OVX + CUMS mice**: The anxiolytic, antidepressant and cognitive - improving effects of Jie - Yu Pill were evaluated through a variety of behavioral tests (such as open - field test, elevated plus - maze test, sucrose preference test, forced swim test, tail suspension test and Morris water maze test). 2. **To explore the mechanism of action of Jie - Yu Pill**: The mechanism of action of Jie - Yu Pill was revealed by detecting the levels of hormones related to the hypothalamic - pituitary - ovarian axis (HPO) and the hypothalamic - pituitary - adrenal axis (HPA) in serum, as well as the expression changes of γ - aminobutyric acid (GABA), glutamate, neurotrophic factors and estrogen receptors in the brain. The research results showed that Jie - Yu Pill had an effect comparable to estrogen treatment in alleviating mood - disorder - like behaviors and cognitive dysfunctions in OVX + CUMS mice, but had a smaller impact on uterine weight. In addition, Jie - Yu Pill could also regulate the activities of the HPO axis and the HPA axis, restore the glutamate content and its receptor expression in the hippocampus and prefrontal cortex, and protect against the reduction of nerve growth factor and estrogen receptor. In conclusion, this study provides a scientific basis for Jie - Yu Pill as a potential treatment method for mental disorders related to menopausal syndrome.